Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2003
12/02/2003US6656705 Sciellin and uses thereof
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656698 12832, a novel human kinase-like molecule and uses thereof
12/02/2003US6656683 Laser scanning cytology with digital image capture
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
12/02/2003US6656489 Scaffold for tissue engineering cartilage having outer surface layers of copolymer and ceramic material
12/02/2003US6656488 Porous bag; insertion into void; conformation into shape
12/02/2003US6656479 Protects a mammal against neosporosis
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
12/02/2003CA2172165C Human receptor h4-1bb
12/02/2003CA2051562C Bacillus thuringiensis isolates active against dipteran pests
12/02/2003CA2046904C Cd4 specific recombinant antibody
11/2003
11/30/2003CA2424427A1 Methods for producing cotyledonary pine embryos utilizing a gibberellin
11/27/2003WO2003098212A2 Method of isolating an endotehelial cell and method of donor specific crossmatching
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
11/27/2003WO2003097844A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/27/2003WO2003097837A1 Stress-responsive gene specific to root
11/27/2003WO2003097836A1 Method of accumulating arbitrary peptide in plant protein granules
11/27/2003WO2003097825A2 Novel phospholipases and uses thereof
11/27/2003WO2003097820A1 Method of utilizing physiological activity of rare saccharide and compositions containing rare saccharide
11/27/2003WO2003097819A1 Cell culture method using marine deep water
11/27/2003WO2003097812A2 Transgenic ungulates capable of human antibody production
11/27/2003WO2003097805A2 Delivery of nucleic acid-like compounds
11/27/2003WO2003097798A2 Carotene synthase gene and uses therefor
11/27/2003WO2003097795A2 Constitutively translocating cell line
11/27/2003WO2003097788A2 Cell culture device
11/27/2003WO2003097787A1 Cell culture device
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003096973A2 A direct cellular energy delivery system
11/27/2003WO2003096972A2 Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
11/27/2003WO2003082189A3 Method for producing pseudo islets
11/27/2003WO2003080638A9 Antisense iap nucleobase oligomers and uses thereof
11/27/2003WO2003080570A3 Recombinant expression vectors for functional nav1.9 sodium channels
11/27/2003WO2003079748A3 Potentiation of cancer therapies by znf217 inhibition
11/27/2003WO2003078613A3 Serine hydroxymethyltransferase as a target for herbicides
11/27/2003WO2003078589A3 Method of identifying genes controlling diferentiation
11/27/2003WO2003078568A3 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
11/27/2003WO2003076469A3 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
11/27/2003WO2003075669A3 Food fermentation with lactic acid bacteria
11/27/2003WO2003073980A3 Recombinant protein c variants
11/27/2003WO2003070765A3 Growth hormone fusion protein
11/27/2003WO2003068802A3 Materials and methods for preparing dimeric growth factors
11/27/2003WO2003068172A3 Undesignated allogeneic stem cell bank
11/27/2003WO2003066661A3 Human dr4 antibodies and uses thereof
11/27/2003WO2003064622A3 Aggrecanase molecules
11/27/2003WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof
11/27/2003WO2003056899A3 Nitric oxide donors for treatment of disease and injury
11/27/2003WO2003056020A3 Expression vectors and promoters for heterologous gene expression
11/27/2003WO2003052083A3 Methods for the generation of proliferating and differentiating cell lines
11/27/2003WO2003052080A3 Pluripotent stem cells derived without the use of embryos or fetal tissue
11/27/2003WO2003044214A3 Methods and compositions in checkpoint signaling
11/27/2003WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis
11/27/2003WO2003042249A3 Peptide purification by means of metal ion affinity chromatography
11/27/2003WO2003037932A3 Human coagulation factor vii polypeptides
11/27/2003WO2003035696A3 Humanized antibodies against icam-1, their production and uses
11/27/2003WO2003031578A3 Mammalian c-type lectins
11/27/2003WO2003031573A3 Toll-like receptor 3 signaling agonists and antagonists
11/27/2003WO2003029464A3 Genes associated with mast cell activation
11/27/2003WO2003027147A3 Human coagulation factor vii polypeptides
11/27/2003WO2003023040A3 Vaccinia virus mva-e3l-knockout-mutants and use thereof
11/27/2003WO2003023023B1 Production and use of human cd124 and cd116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003016481A3 Novel human collagen proteins and polynucleotides encoding the same
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2003001981A3 Method of promoting engraftment of a donor transplant in a recipient host
11/27/2003WO2002102299A3 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
11/27/2003WO2002099059A3 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
11/27/2003WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2003WO2002094881A3 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/27/2003WO2002092771A3 Specific binding proteins and uses thereof
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002089737A3 Separation of platelets from whole blood for use as a healant
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002081632A3 Nucleic acids for transgene expression
11/27/2003WO2002077272A3 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
11/27/2003WO2002074964A3 Polypeptides derived from rna polymerases and use thereof
11/27/2003WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
11/27/2003WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
11/27/2003WO2002068459A3 Non aggregating fluorescent proteins and methods for using the same
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002063010A3 Method of producing recombinant antibodies against tumors
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002050113A3 Interleukin-1 related gene and protein
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003US20030221221 Preparing transgenic plant with increased growth rate, flowers and seed yield
11/27/2003US20030221216 Wound-inducible expression in plants
11/27/2003US20030221215 Comprises nucleotide sequences for preventing oomycete infection of potato and/or tomato; disease resistant plants
11/27/2003US20030221214 Citrus tristeza virus resistance genes and methods of use
11/27/2003US20030221210 Method for introducing a gene into a plant using and adventitious bud redifferentiation gene under the control of a light-inducible promoter as a selectable marker gene, and vector for introducing a gene into a plant using the same
11/27/2003US20030221206 Using in vitro fertilization to produce gentically engineered animals for use as models for prevention and treatment of disease
11/27/2003US20030221205 Olfactory and pheromones G-protein coupled receptors
11/27/2003US20030220692 Preparations of nucleus pulposus cells and methods for their generation, identification, and use
11/27/2003US20030220674 Methods and devices for selective disruption of fatty tissue by controlled cooling
1 ... 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 ... 1827